Introduction
Linear IgA bullous dermatosis (LABD)l is a rare acquired subepidermal blistering disease of the skin which has been defined on the basis of its unique immunopathologic finding of linear IgA along the cutaneous basement membrane (1) . LABD was initially considered to be a variant of dermatitis herpetiformis (2) . However, LABD has been separated from classical dermatitis herpetiformis that demonstrates granular deposition of IgA in dermal papillary tips. Patients with dermatitis herpetiformis also have a high frequency of the HLA B8 DR3 haplotype, and gluten-sensitive enteropathy, which is not present in LABD patients (3, 4) . Some patients with LABD demonstrate a circulating IgA-class anti-basement membrane antibody on indirect immunofluorescence, whereas sera from patients with dermatitis herpetiformis have not demonstrated a circulating antibody that binds to skin (2) . Immunoelectron microscopy in LABD reveals two patterns of IgA deposition. One group has immunoglobulin deposition in the sublamina densa, whereas the second group shows deposition of immunoglobulin in the lamina lucida (5) (6) (7) (8) .
LABD can also be contrasted with other subepidermal blistering diseases of the skin on the basis of immunopathology. Both epidermolysis bullosa acquisita and bullous pemphigoid demonstrate the deposition of IgG-class antibody along the basement membrane on direct immunofluorescence and frequently a circulating IgG-class anti-basement membrane antibody. The epidermolysis bullosa acquisita antigen has been identified as a 290-kD protein that is type VII collagen and is present in the sub-basal lamina (9, 10) . The major bullous pemphigoid antigen has been identified as a 240-kD epidermal protein present in the lamina lucida (1 1, 12) . Because some patients with LABD have deposition of IgA in the lamina lucida, LABD has been referred to as "IgA pemphigoid" by some, implying that it is simply an IgA-class immune response to the bullous pemphigoid antigen (7) .
We present evidence here that sera from patients with linear IgA disease contain an IgA-class antibody that selectively binds a 97-kD protein extracted from both normal human epidermis and dermis. This antigen differs from the major bullous pemphigoid antigen and the epidermolysis bullosa acquisita antigen on the basis of molecular weight and tissue distribution. Moreover, we show that this antibody can be isolated using both the human basement membrane zone and nitrocellulose as an immunoabsorbent. Antibody isolated by these techniques reacts uniquely with basement membrane and the 97-kD protein.
Methods
Patient sera. Sera from 10 Immunoelectron microscopy. Immunoelectron microscopy was performed on patients 2 and 3 (Table I) Towbin (16) . LABD sera and normal human sera were diluted 1:10, epidermolysis bullosa acquisita serum was diluted 1:200, and bullous pemphigoid serum 1:100 in PBS with 0.5% BSA and 0.05% Tween 20 (ATPBS). Diluted sera were incubated with sectioned nitrocellulose sheets and developed using biotin-labeled second antibody and an avidin-biotin-peroxidase complex as described previously (17) . Reaction times for all lanes of individual blots are identical.
Several specific antibodies were used for studies to characterize the location of separation of EDTA and saline-split skin. Mouse monoclonal antibody to laminin (Calbiochem-Behring Corp., San Diego, CA) was used at a dilution of 1:50 and the second antibody was fluorescein-conjugated goat antimouse IgG (IgG fraction, 13.5 mg/ml protein, 4 10 min, and the supernatant discarded. The pellet was washed for 10 min three times in PBS, and then incubated in 5 cm3 of20 mM sodium citrate (pH 3.2) for 6 h at 37°C. After centrifugation at 3,000 g for 10 min, the supernatant was decanted and Indirect immunofluorescence and Western blot of nitrocellulose immunoaffinity-purified serum. Protein bands on nitrocellulose blots of Laemmli gels were also used as immunoaffinity substrates to purify antibodies directed against specific proteins in dermal extract as described by Olmsted (18) and modified by Smith and Fisher (19) . Vertical lanes from both sides of the nitrocellulose imprint of the gel were cut and immunochemically stained with sera to identify the bands of interest. Horizontal strips of nitrocellulose containing the antigen of interest, but not exposed to sera, were then cut and sera applied as 1:5 dilution in ATPBS for 2 h. After washing in ATPBS, the antibodies were eluted in 600,ul 20 mM sodium citrate (pH 3.2), 0.05% Tween-20 for 3 min at 370C, and were immediately neutralized with 2.0 M Tris HCI (pH 7.5) to a final pH of 6.8.
Results
Indirect immunofluorescence. Indirect immunofluorescence with LABD sera was performed with both monkey esophagus and saline-split normal human skin as substrates and developed with both fluorescein-conjugated anti-IgA and anti-IgG. No (20) . It should also be noted that all patients showed at least a one-tube dilution greater titer when salinesplit skin was used as a tissue source. 14 normal human sera were also tested in this manner and all were negative on indirect immunofluorescence for both antibody classes. Patient 4 is the patient with cicatrizing conjunctivitis without skin lesions.
Specific fluorescence was noted only at the basement membrane on the epidermal side of the split skin. No specific dermal fluorescence was noted.
Western blots of epidermal extract. Western blots of epidermal extracts were performed using skin separated by both epidermal extract obtained by both techniques were used for Western blots, exposed to sera, and developed with avidinbiotin-peroxidase complex. The Western blot of epidermal extract obtained from 1 M saline-split skin showed no consistent antigen recognized by LABD sera, and the 97-kD band subsequently discussed was not noted on these blots (data not shown). The Western blots ofepidermal extract obtained from 20 mM EDTA split skin exposed to LABD sera are shown in Fig. 3 . Lane I is the no-primary antibody control. Lanes 2-4 are patients with LABD (patients 1-3, Table I ). Results on patient 4 were similar (not shown). Lanes 5-7 were exposed to the normal human sera. All lanes were stained with anti-IgA. Several bands are recognized by sera from these patients with LABD; a consistent band at 97 kD, as well as a variety of other less consistent bands. The remainder of the LABD sera failed to demonstrate the 97-kD band, but did show a number of less consistent bands (not shown). Relatively high protein concentration and low serum dilutions (1:10) were used to maximize sensitivity. As a result, increased background is noted with multiple bands in both test sera and normal sera. The positive control lane was exposed to bullous pemphigoid serum and developed with anti-IgG; it demonstrated a 240-kD band (not shown).
Western blot of dermal extract. Fig. 4 demonstrates the Western blots of dermal extract prepared from EDTA-split skin exposed to sera and developed with avidin-biotin-peroxidase complex. Lanes 1-6 are LABD sera (patients 1-6, Table  I ) stained with anti-IgA. Lane 4 is serum from the patient with cicatrizing conjunctivitis. Lanes 7-9 are normal sera. A band in the 97-kD range is noted with LABD and cicatrizing conjunctivitis patient sera. This becomes minimally detectable when sera with lower antibody titers are used (lanes 5 and 6). An additional dense 38-kD band is noted with the cicatrizing conjunctivitis patient serum. The positive control lane was exposed to epidermolysis bullosa acquisita serum developed with anti-IgG and showed a characteristic 290-kD band as well as some nonspecific staining (not shown (patients 7-10 in Table I ) failed to produce a band with dermal extract (data not shown). Since these negative sera were the ones with the lowest titer of antibody, it was felt that lack of sensitivity was the likely reason for negative Western blots on these specimens. Control sera from 10 patients with bullous pemphigoid, 5 patients with pemphigus vulgaris, and 2 patients with epidermolysis bullosa acquisita were also evaluated for antibodies of IgA class against the 97-and 112-kD band. No reactivity of these sera was noted. We have previously reported similar Western blot analysis of 63 patients with der-1 2 Western blot of dermal extract stained with ZIA-purified serum (Fig. 6) . The Western blot of the dermal extract stained with ZIA-purified patient sera is shown in Fig. 6 . Lanes 1-4 are stained with the LABD sera, lane '4 is the serum from the cicatrizing conjunctivitis patient, and lanes la-4a represent the corresponding ZIA-purified sera all stained for IgA. Lanes 5-6 are normal human sera, and lane 5a-6a are ZIA purification of normal human sera, stained for IgA. All patients demonstrated persistence of the 97-kD band after the ZIA procedure. The cicatrizing conjunctivitis patient demonstrated purification of both a 38-as well as a 97-kD band (lane 4a). The ZIA-purified specimens eliminate the considerable background produced by using test sera at low titers and high tissue extract concentrations. Dense bands that would seem to be of great importance are eliminated after purification (lane la).
Indirect immunofluorescence and Western blot ofnitrocellulose immunoaffinity-purified serum. To further confirm that the antigen detected on immunoblot corresponded with the antigen detected using immunofluorescence, we used nitrocellulose blots of dermal extract as an affinity substrate for antibody purification and probed epidermis with the resulting antibody. Antibody was eluted from the 145-, 97-, and 55-kD bands of dermal extract as described in Methods and reacted with the basement membrane zone of EDTA-split epidermis with indirect immunofluorescence (Fig. 7) . This demonstrates that the antibody reactive with the 97-kD, but not the 145-and 55-kD proteins, reacts with basement membrane zone. Nitrocellulose strips are stained with patient serum at 1: 1O dilution and developed with avidin-biotin-peroxidase complex and anti-IgA. Lanes 1-6 are incubated with LABD patient sera. Lane 4 is the cicatrizing conjunctivitis patient serum, and lanes [7] [8] [9] are normal human sera. A band is noted from LABD sera in the 97-kD region, although all sera identify several other bands, some of which are more dense. The cicatrizing conjunctivitis serum detects an additional band at 38 kD. Significant background is noted due to low serum dilutions. (Table I) .
To establish that the 97-kD band reactive in epidermal extract was the same antigen as that found in dermal extract, we used antibody eluted from the 97-kD band on nitrocellulose blots of dermal extract. This revealed specific staining of only the 97-kD band on blots of epidermal extract and was done with sera from both patients 1 and 2 (not shown).
We conclude from the nitrocellulose elution studies that the antibody reactive with the 97-kD band on dermal and epidermal extract is the antibody in serum that is responsible for the basement membrane zone staining seen on indirect immunofluorescence of serum.
Discussion
LABD is an uncommon blistering disease of the skin in which a vesicle forms in the basement membrane zone in association with the linear deposition of IgA in perilesional skin (1, 4, 7 IgA-class autoantibodies that bound to the basement membrane of monkey esophagus, a common substrate for detection of basement membrane autoantibodies. When indirect immunofluorescence was performed on our sera using 1 M salinesplit skin as a substrate, 9 of 10 LABD sera demonstrated circulating IgA-class anti-basement membrane antibody, pointing out the superiority of saline-split skin as a substrate for detection oflow titer basement membrane zone antibodies. 1 M NaCl has been shown to separate the basement membrane zone through the lamina lucida leaving the bullous pemphigoid antigen on the epidermal side and components of the lamina densa and subbasal lamina on the dermal side (22, 23) . EDTA also produces epidermal separation and we have shown that 20 mM EDTA produces a separation similar to 1 M NaCl (24) . Consequently, antibody that reacts to the epidermal portion of split human skin is binding at the lamina lucida or above. All nine of our positive sera showed binding to the epidermal portion of the saline-split skin, indicating that the IgA was directed toward an antigen within or above the lamina lucida as is the case with IgG in bullous pemphigoid. This was confirmed in two patient biopsies by direct immunoelectron microscopy. Therefore, it would appear that none of our patients had the subbasal lamina type of IgA deposition described by others. LABD is an uncommon disease and we have no further explanation for the paucity of such cases in our series.
We initially evaluated high concentrations of epidermal and dermal extracts of saline-split skin for binding of LABD IgA-class antibodies. We were unable to identify any consistent pattern on epidermal extract but were able to identify a consistent band at 97 kD in dermal extract using the four highest titer sera. Because these IgA-class antibodies were found to react with the epidermal portion of saline-split skin on indirect immunofluorescence, we would have expected the sera to react with epidermal extract rather than dermal extract. When EDTA-split skin was used as a source for epidermal extract, we were able to identify the 97-kD band within epidermal extract. The amount of antigen, however, appears to be greater in dermal extract under all conditions, for with similar concentrations of extract, the 97-kD protein band is more intense on dermal extract and was recognized by three additional sera. It seems likely that the relatively harsh conditions of 1 M NaCl separation in combination with the extraction procedure quantitatively decreased the immunoreactivity of the putative antigen on Western blot while preserving some immunoreactivity on immunofluorescence. EDTA is a protease inhibitor as well as an agent that produces basement membrane zone separation and is likely to minimize protein denaturation. Large amounts of soluble antigen could then be extracted from dermis, but not recognized as discrete fluorescence. Extraction of the epidermis and the basement membrane would then yield only small amounts of antigen which were minimally detectable by our low titer antibody. This would explain the small amount of the LABD antigen in epidermal extract and its presence in dermal extract. In contrast, the bullous pemphigoid antibody has been regularly extracted from the epidermal portion of the split skin (12, 13) . However this antigen has also been shown to be produced by keratinocytes which are present in the tissue being extracted. It seems possible that the relatively harsh extraction conditions could release intracellular keratinocyte proteins which might well be responsible for the majority of antigens detected by bullous pemphigoid serum on Western blot rather than antigen bound at the basement membrane.
Because we used low dilutions of serum antibody and high concentrations of extract, several bands that we believed to be nonspecific were seen on Western blot of both the epidermal and dermal extract with LABD sera. Immunoaffinity purification of antibody with epidermis allowed elimination of such background and easy identification of bands by eliminating large quantities of nonspecific protein. We then sought to confirm the specificity of the 97-kD antigen by a second line of investigation. We used nitrocellulose blots as an affinity substrate for antibody purification and then probed epidermis and dermis with the resulting antibody. This showed that the IgAclass antibody eluted from the 97-kD antigen reacted with basement membrane, whereas antibody eluted from other bands on the blot failed to react with basement membrane as evaluated by immunofluorescence. The efficacy of elution from nitrocellulose and the maintenance of immunoreactivity ofthese solutions was confirmed by Western blots and demonstrated what we interpret to be shared epitopes in some cases.
The antigen identified by our LABD sera appears to be distinct from the antigen identified by Stanley and co-workers (12) because this antigen has been described as varying in size between 220 and 240 kD and the antigen identified by LABD sera is 97 kD. Staining ofour extracts with bullous pemphigoid and epidermolysis bullosa acquisita sera showed that classical 240-kD bullous pemphigoid band on epidermal extract and 290-kD epidermolysis bullosa acquisita band on dermal extract, indicating that these antigens were preserved by our extraction procedures, but not recognized by our LABD sera. Therefore, it seems reasonable to conclude that the LABD antigen in lamina lucida-type LABD is distinct from the classical 240-kD bullous pemphigoid band, and LABD does not simply represent an IgA-class immune response to the bullous pemphigoid antigen. Labib and co-workers have described occasional bullous pemphigoid sera that recognize a 97-kD protein (13) . Whether this is the same antigen recognized by our LABD sera will require further investigation.
Interestingly, our single cicatrizing conjunctivitis without cutaneous lesions showed an additional band present in both epidermal and dermal extract which was 38 kD in size. This protein was still specific after ZIA. It is impossible to tell what role this antigen might be playing in the differential expression of disease. We present these results for interest and hope that these data will be expanded by the experience of others in this rare disease.
